Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan okyopharma.com (OKYO)

OKYO Pharma Ltd (OKYO) - logo korporat

OKYO Pharma Limited (OKYO) aims to develop high-margin dry eye treatments with a sustained demand cycle. However, geopolitical tensions and logistical collapses are hindering the execution of global trials. The company's financial stability relies solely on external investments in the absence of its own cash flow. The quarterly EPS change illustrates these imbalances, with the parameter reaching -115.00, signaling the current profit dynamics.

Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan OKYO Pharma (OKYO): kanggo periode 27.06.2023 - 17.11.2026

Rincian analitis perusahaan OKYO Pharma Limited

- rega saham lan prakiraan rega para ahli:
Analisis komprehensif perusahaan:okyopharma.com, OKYO
Produk dadi okyopharma.com

This indicator measures the rate of change in earnings per share (EPS) on a quarterly basis, allowing analysts to filter out management optimism and identify real market demand through yield dynamics. Analyzing quarterly EPS growth helps assess the extent to which the financial success of OKYO Pharma Limited (OKYO) is supported by the efficiency of small research teams developing innovative treatments for dry eye syndrome.

Karo sapa OKYO Pharma Limited saingan

Alcon Corp (ALC) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Bausch Health (BLCO)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan glaukos.com|Apellis Pharmaceuticals (APLS) - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan BLTE|OCUL - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan HROW (Harrow Inc)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan Viridian Corp (VRDN)|LENZ - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Oculis - Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|EyePoint Pharmaceuticals (EYPT) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Kodiak Sciences Inc (KOD) - Wutah bathi EPS kuartalan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan ALDX|KALA: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan IRD|Wutah bathi EPS kuartalan Adverum Biotechnologies Inc. (ADVM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan outlooktherapeutics.com OTLK|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan Clearside Biomedical, Inc. (CLSD)|NBY - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan KPRX (kiorapharma.com)|Alimera Sciences (ALIM) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Eyenovia Inc. - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|GHSI (Guardion Health Sciences) - Wutah bathi EPS kuartalan|Ocuphire Pharma - Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan OPT (Opthea)